CasNo.52212-02-9,4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide,(52212-02-9) Suppliers

1 Gram	Negotiable

Min.Order :1 Gram
Purity: 98%
Payment Terms : T/T

Keywords

Pipecuronium bromide (USAN) RGH 1106 Arduan (TN)

Quick Details

Appearance: Solid
Application: Pipecuronium Bromide is a muscle relaxant and an anaesthesia used in patients undergoing coronary artery bypass graft surgery.
PackAge:According to the need to packing
ProductionCapacity:25|Kilogram|Week
Storage:Store at -20°C
Transportation:Air,sea and courier

Superiority:

Product Name: Pipecuronium bromide

Synonyms: pipecuronium bromide;4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide;4,4'-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetoxy)androstane-2,16-diyl]bis[1,1-dimethylpiperazinium] dibromide;PIPECURIUM BROMIDE;Pipecuronium;PIPECURINIUM BROMIDE;4，4’-[(2β，3α，5α，16β，17β)-3，17-Bis(acetoxy)andrc~tane-2，16-diyl]bis(1，1-dimethylpiperazinium)dibromide;Ardtm

CAS: 52212-02-9

MF: C35H62Br2N4O4

MW: 762.69918

EINECS: 257-740-4

Product Categories:

Mol File: 52212-02-9.mol

Pipecuronium bromide Structure

Pipecuronium bromide Chemical Properties

Melting point 262-264° (dec)

alpha D25 +8.1° (c = 1 in water)

storage temp. Store at -20°C

solubility DMSO, Methanol (Slightly), Water (Slightly)

form Solid

color White to Off-White

CAS DataBase Reference 52212-02-9(CAS DataBase Reference)

Safety Information

Toxicity LD50 in mice, rats (mg/kg): 29.7, 172.6 i.v.; 70.6, 449.6 i.p.; 60.5, 455.8 s.c. (Kárpáti, Biro)

Details:

Uses Pipecuronium Bromide is a muscle relaxant and an anaesthesia used in patients undergoing coronary artery bypass graft surgery.

Definition ChEBI: Pipecuronium bromide is a steroid ester.

Brand name Arduan (Organon).

General Description Pipecurium bromide, 4,4 -(3 ,17 -dihydroxy-5 -androstan-2 ,16 -ylene)bis(1,1-dimeth-ylpiperazinium)dibromide diacetate (Arduan), is anondepolarizing muscle relaxant similar, both chemicallyand clinically, to pancuronium bromide. It is a long-actingdrug indicated as an adjunct to anesthesia and in patients undergoingmechanical ventilation.

Pharmacology Pipecuronium bromide, an analogue of pancuronium, was developed in Hungary in 1980 and is marketed in Eastern Europe and the United S tates. The intubating dose is 0.07 mg kg–1. The onset time and time to recovery from block are similar to those of pancuronium, and excretion of the drug through the kidneys is significant (66%). In contrast to pancuronium, pipecuronium produces marked cardiovascular stability, having no vagolytic or sympathomimetic effects. It may therefore be useful during major surgery in patients with cardiac disease.